Notably, while the effect of genetically regulated LDL cholesterol on CAD risk was even higher at the LDLR and PCSK9 loci, the effect on T2D was strongly attenuated relative to HMGCR (56). The gene discussed is PCSK9; the disease is type 2 diabetes mellitus.